Adverse event during Covaxin trials: Bharat Biotech confirms.

Spread the love
Adverse event during Covaxin trials: Bharat Biotech confirms.
Bharat Biotech confirms that there was a adverse event during coronavirus vaccine trials in August 2020. According to Bharat Biotech-
  • They have reported to ADSCO-DCGI, within 24 hours of occurrence of the event.
  • They have rejected the report that it did not report an adverse event during trial in August.
  • Bharat Biotech and ICMR jointly working on indigenous coronavirus vaccine candidate.
  • CDSCO has also given its approval to Bharat Biotech to launch the phase III trials of COVID-19 vaccine candidate.

Leave a Reply

Your email address will not be published. Required fields are marked *